Cargando…
S191: PIVOTAL PHASE 2 MONUMENTAL-1 RESULTS OF TALQUETAMAB (TAL), A GPRC5DXCD3 BISPECIFIC ANTIBODY (BSAB), FOR RELAPSED/REFRACTORY MULTIPLE MYELOMA (RRMM)
| Autores principales: | , , , , , , , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Lippincott Williams & Wilkins
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10428341/ http://dx.doi.org/10.1097/01.HS9.0000967676.59550.94 |
| _version_ | 1785090445435469824 |
|---|---|
| author | Touzeau, Cyrille Schinke, Carolina Minnema, Monique van de Donk, Niels W.C.J. Rodríguez-Otero, Paula Mateos, Maria-Victoria Rasche, Leo Ye, Jing Christine Vishwamitra, Deeksha MA, Xuewen Qin, Xiang Campagna, Michela Masterson, Tara Hilder, Brandi Tolbert, Jaszianne Renaud, Thomas Goldberg, Jenna Heuck, Christoph Chari, Ajai |
| author_facet | Touzeau, Cyrille Schinke, Carolina Minnema, Monique van de Donk, Niels W.C.J. Rodríguez-Otero, Paula Mateos, Maria-Victoria Rasche, Leo Ye, Jing Christine Vishwamitra, Deeksha MA, Xuewen Qin, Xiang Campagna, Michela Masterson, Tara Hilder, Brandi Tolbert, Jaszianne Renaud, Thomas Goldberg, Jenna Heuck, Christoph Chari, Ajai |
| author_sort | Touzeau, Cyrille |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-10428341 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2023 |
| publisher | Lippincott Williams & Wilkins |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-104283412023-08-17 S191: PIVOTAL PHASE 2 MONUMENTAL-1 RESULTS OF TALQUETAMAB (TAL), A GPRC5DXCD3 BISPECIFIC ANTIBODY (BSAB), FOR RELAPSED/REFRACTORY MULTIPLE MYELOMA (RRMM) Touzeau, Cyrille Schinke, Carolina Minnema, Monique van de Donk, Niels W.C.J. Rodríguez-Otero, Paula Mateos, Maria-Victoria Rasche, Leo Ye, Jing Christine Vishwamitra, Deeksha MA, Xuewen Qin, Xiang Campagna, Michela Masterson, Tara Hilder, Brandi Tolbert, Jaszianne Renaud, Thomas Goldberg, Jenna Heuck, Christoph Chari, Ajai Hemasphere Oral Sessions Lippincott Williams & Wilkins 2023-08-08 /pmc/articles/PMC10428341/ http://dx.doi.org/10.1097/01.HS9.0000967676.59550.94 Text en Copyright © 2023 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially. |
| spellingShingle | Oral Sessions Touzeau, Cyrille Schinke, Carolina Minnema, Monique van de Donk, Niels W.C.J. Rodríguez-Otero, Paula Mateos, Maria-Victoria Rasche, Leo Ye, Jing Christine Vishwamitra, Deeksha MA, Xuewen Qin, Xiang Campagna, Michela Masterson, Tara Hilder, Brandi Tolbert, Jaszianne Renaud, Thomas Goldberg, Jenna Heuck, Christoph Chari, Ajai S191: PIVOTAL PHASE 2 MONUMENTAL-1 RESULTS OF TALQUETAMAB (TAL), A GPRC5DXCD3 BISPECIFIC ANTIBODY (BSAB), FOR RELAPSED/REFRACTORY MULTIPLE MYELOMA (RRMM) |
| title | S191: PIVOTAL PHASE 2 MONUMENTAL-1 RESULTS OF TALQUETAMAB (TAL), A GPRC5DXCD3 BISPECIFIC ANTIBODY (BSAB), FOR RELAPSED/REFRACTORY MULTIPLE MYELOMA (RRMM) |
| title_full | S191: PIVOTAL PHASE 2 MONUMENTAL-1 RESULTS OF TALQUETAMAB (TAL), A GPRC5DXCD3 BISPECIFIC ANTIBODY (BSAB), FOR RELAPSED/REFRACTORY MULTIPLE MYELOMA (RRMM) |
| title_fullStr | S191: PIVOTAL PHASE 2 MONUMENTAL-1 RESULTS OF TALQUETAMAB (TAL), A GPRC5DXCD3 BISPECIFIC ANTIBODY (BSAB), FOR RELAPSED/REFRACTORY MULTIPLE MYELOMA (RRMM) |
| title_full_unstemmed | S191: PIVOTAL PHASE 2 MONUMENTAL-1 RESULTS OF TALQUETAMAB (TAL), A GPRC5DXCD3 BISPECIFIC ANTIBODY (BSAB), FOR RELAPSED/REFRACTORY MULTIPLE MYELOMA (RRMM) |
| title_short | S191: PIVOTAL PHASE 2 MONUMENTAL-1 RESULTS OF TALQUETAMAB (TAL), A GPRC5DXCD3 BISPECIFIC ANTIBODY (BSAB), FOR RELAPSED/REFRACTORY MULTIPLE MYELOMA (RRMM) |
| title_sort | s191: pivotal phase 2 monumental-1 results of talquetamab (tal), a gprc5dxcd3 bispecific antibody (bsab), for relapsed/refractory multiple myeloma (rrmm) |
| topic | Oral Sessions |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10428341/ http://dx.doi.org/10.1097/01.HS9.0000967676.59550.94 |
| work_keys_str_mv | AT touzeaucyrille s191pivotalphase2monumental1resultsoftalquetamabtalagprc5dxcd3bispecificantibodybsabforrelapsedrefractorymultiplemyelomarrmm AT schinkecarolina s191pivotalphase2monumental1resultsoftalquetamabtalagprc5dxcd3bispecificantibodybsabforrelapsedrefractorymultiplemyelomarrmm AT minnemamonique s191pivotalphase2monumental1resultsoftalquetamabtalagprc5dxcd3bispecificantibodybsabforrelapsedrefractorymultiplemyelomarrmm AT vandedonknielswcj s191pivotalphase2monumental1resultsoftalquetamabtalagprc5dxcd3bispecificantibodybsabforrelapsedrefractorymultiplemyelomarrmm AT rodriguezoteropaula s191pivotalphase2monumental1resultsoftalquetamabtalagprc5dxcd3bispecificantibodybsabforrelapsedrefractorymultiplemyelomarrmm AT mateosmariavictoria s191pivotalphase2monumental1resultsoftalquetamabtalagprc5dxcd3bispecificantibodybsabforrelapsedrefractorymultiplemyelomarrmm AT rascheleo s191pivotalphase2monumental1resultsoftalquetamabtalagprc5dxcd3bispecificantibodybsabforrelapsedrefractorymultiplemyelomarrmm AT yejingchristine s191pivotalphase2monumental1resultsoftalquetamabtalagprc5dxcd3bispecificantibodybsabforrelapsedrefractorymultiplemyelomarrmm AT vishwamitradeeksha s191pivotalphase2monumental1resultsoftalquetamabtalagprc5dxcd3bispecificantibodybsabforrelapsedrefractorymultiplemyelomarrmm AT maxuewen s191pivotalphase2monumental1resultsoftalquetamabtalagprc5dxcd3bispecificantibodybsabforrelapsedrefractorymultiplemyelomarrmm AT qinxiang s191pivotalphase2monumental1resultsoftalquetamabtalagprc5dxcd3bispecificantibodybsabforrelapsedrefractorymultiplemyelomarrmm AT campagnamichela s191pivotalphase2monumental1resultsoftalquetamabtalagprc5dxcd3bispecificantibodybsabforrelapsedrefractorymultiplemyelomarrmm AT mastersontara s191pivotalphase2monumental1resultsoftalquetamabtalagprc5dxcd3bispecificantibodybsabforrelapsedrefractorymultiplemyelomarrmm AT hilderbrandi s191pivotalphase2monumental1resultsoftalquetamabtalagprc5dxcd3bispecificantibodybsabforrelapsedrefractorymultiplemyelomarrmm AT tolbertjaszianne s191pivotalphase2monumental1resultsoftalquetamabtalagprc5dxcd3bispecificantibodybsabforrelapsedrefractorymultiplemyelomarrmm AT renaudthomas s191pivotalphase2monumental1resultsoftalquetamabtalagprc5dxcd3bispecificantibodybsabforrelapsedrefractorymultiplemyelomarrmm AT goldbergjenna s191pivotalphase2monumental1resultsoftalquetamabtalagprc5dxcd3bispecificantibodybsabforrelapsedrefractorymultiplemyelomarrmm AT heuckchristoph s191pivotalphase2monumental1resultsoftalquetamabtalagprc5dxcd3bispecificantibodybsabforrelapsedrefractorymultiplemyelomarrmm AT chariajai s191pivotalphase2monumental1resultsoftalquetamabtalagprc5dxcd3bispecificantibodybsabforrelapsedrefractorymultiplemyelomarrmm |